Publication:
Impact of Antecedent Aspirin Use on Infarct Size, Bleeding and Composite Endpoint in Patients with de Novo Acute Myocardial Infarction

Simple item page
dc.contributor.authorENHOŞ, Asim
dc.contributor.authorKARAÇÖP, ERDEM
dc.contributor.institutionauthorENHOŞ, ASIM
dc.contributor.institutionauthorKARAÇÖP, ERDEM
dc.date.accessioned2021-08-07T20:59:07Z
dc.date.available2021-08-07T20:59:07Z
dc.date.issued2021-01-01T00:00:00Z
dc.description.abstractBackground: The study aimed to evaluate the impact of antecedent aspirin use on infarct size, bleeding and composite endpoint in patients with de novo acute myocardial infarction. Patients and methods: A total of 562 consecutive patients with de novo acute myocardial infarction were included in this prospective cohort study. Patients were assigned into two groups based on presence (n=212) and absence (n=350) of prior aspirin use. Primary endpoint was myocardial infarct size, as estimated by troponin I peak. In-hospital mortality, bleeding and composite clinical endpoint including cardiogenic shock, stroke, in-hospital mortality and major bleeding were also evaluated. Results: Although GRACE and CRUSADE scores were higher, troponin I peak was lower in prior aspirin users. This result was maintained after adjustment for baseline ischemic risk profile and other major confounders including MI type and location. Despite high CRUSADE score, there was no increase in major and minor bleeding. Minimal bleeding was higher in antecedent aspirin users. When it was adjusted for the CRUSADE score, a similar risk was reported. Conclusion: Patients with de novo acute myocardial infarction using aspirin for primary prevention have an unexpectedly smaller infarct size and similar bleeding rates.
dc.identifier.doi10.2147/tcrm.s307768
dc.identifier.pubmed34054296
dc.identifier.urihttp://hdl.handle.net/20.500.12645/29127
dc.identifier.wosWOS:000653048800001
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectacute myocardial infarction
dc.subjectaspirin
dc.subjectinfarct size
dc.subjectprimary prevention
dc.titleImpact of Antecedent Aspirin Use on Infarct Size, Bleeding and Composite Endpoint in Patients with de Novo Acute Myocardial Infarction
dc.typeArticle
dspace.entity.typePublication
local.avesis.id5e1bf5cf-517f-40cd-8473-c9a29b3ca7f5
local.publication.isinternational1
relation.isAuthorOfPublicationc3607d35-33d0-4cb4-9fde-e72042628ef1
relation.isAuthorOfPublicationd764645a-8974-46cc-b839-17dc2938c958
relation.isAuthorOfPublication.latestForDiscoveryd764645a-8974-46cc-b839-17dc2938c958
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Impact of Antecedent Aspirin Use on Infarct Size, Bleeding and Composite Endpoint in Patients with de Novo Acute Myocardial Infarction.pdf
Size:
592.23 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Yayınlar - Eserler